News Conference News TCT 2014 COMPARE II: STEMI Patients See Strong Results with Both BES and EES September 14, 2014
News Conference News TCT 2014 PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis September 13, 2014
News Conference News TCT 2014 Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions September 13, 2014
News Conference News TCT 2013 Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit November 03, 2013
News Conference News TCT 2013 SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study October 30, 2013
News Conference News TCT 2013 COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI October 28, 2013
News Conference News TCT 2012 COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial November 02, 2012
News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 31, 2012
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
News Conference News TCT 2012 ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD October 24, 2012
News Conference News TCT 2012 Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology October 24, 2012
News Conference News TCT 2012 DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS October 24, 2012
News Conference News TCT 2012 STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting October 23, 2012
News Conference News TCT 2012 Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year October 22, 2012